Ratings Moves: AIR,...
Health Care: Drugs
Achillion Pharmaceuticals Inc. (ACHN: NASDAQ)
$7.77 0.21 | 2.78%
05/17/13 - 04:00 PM ET
823.36K / 1.13M
Vol / Avg. Vol:7.60 / 7.56
Open / Prev. Close:7.56 - 7.82
Today's Range:5.42 - 11.36
52 Wk Range:-5.62%
Performance YTD:TheStreet Rating:
Portfolios with ACHN
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorBreakout Stocks Of The Week...
- UserMy Watch List
- ContributorStocks Under-$10 Setting Up...
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Rising On Unusual Vo...
- UserThe cash burners
- ContributorStocks Under-$10 Moving Hig...
Latest ACHN Headlines from TheStreet
- Achillion Appoints Dr. David Apelian As Chief Medical Officer And Expands Clinical Operations Team 05.15.13 | 06:05 am
- Achillion To Present At Three Upcoming Investor Conferences 05.09.13 | 06:05 am
- Achillion Reports First Quarter 2013 Financial Results 05.07.13 | 06:05 am
- Oversold Conditions For Achillion Pharmaceuticals 05.02.13 | 12:05 pm
- Achillion Presents New Data On ACH-3102 To Treat Hepatitis C At The International Liver Congress 04.23.13 | 06:04 am
- Achillion Announces Updated Phase 2 Results Including Early Sustained Virologic Response On ACH-3102 Plus Ribavirin In Genotype 1b Treatment-Naive Hepatitis C Patients 04.23.13 | 06:04 am
- Achillion Initiates Phase 2 Interferon-Free Trial Of Sovaprevir And ACH-3102 For Genotype 1 HCV 04.16.13 | 06:04 am
- Most Profitable Second Quarter Biotech Stocks 04.02.13 | 06:04 am
- Achillion To Present At Two Upcoming Investor Conferences 03.01.13 | 06:03 am
- Achillion Pharmaceuticals Announces Closing Of Public Offering 02.27.13 | 04:02 pm
Press Releases for ACHN
- Emerald Holds Annual Groundhog Day Investment Forum - Business Wire 02.06.12 | 08:02 am
Partner Headlines for ACHN
- Gilead Stock Hits New High As HCV Drug Keeps Rocking - Investor's Business Daily 02.19.13 | 04:02 pm
- New Second Generation Combination Therapy For HCV - First Or Best In The Market - Part 3 - Seeking Alpha 11.30.12 | 08:11 am
- Cramer's Mad Money - 8 Things To Watch In The Week Ahead (9/28/12) - Seeking Alpha 09.30.12 | 07:09 am
- Achillion Pharma draws bullish bet - NASDAQ 09.25.12 | 04:09 pm
- 3 Stocks Upgraded On September 19 To Consider - Seeking Alpha 09.21.12 | 10:09 am
- Morning Market Movers - Benzinga 09.19.12 | 09:09 am
- REVEALED: New Analyst Stock Coverage to Assess Today - Wall St. Cheat Sheet 06.13.12 | 04:06 am
- Stock Insights: Achillion Pharmaceuticals, DG FastChannel, Tempur Pedic, Iron Mountain, Nasdaq OMX June 7th - Wall St. Cheat Sheet 06.07.12 | 10:06 am
- Achillion Announces 94 - 100% Complete EVR From Phase 2 Trial With ACH-1625 Based Regimen in Hepatitis C - Benzinga 04.21.12 | 04:04 pm
- UPDATE: Bank of America Raises Actuant's PT - Benzinga 03.08.12 | 01:03 pm
